Hospital Updates

Takeda Biopharmaceuticals showcases digital healthcare solutions at G20 meeting to improve patient outcomes and drive healthcare access

Takeda Biopharmaceuticals India Private Limited, a global biopharmaceutical leader, showcased its cutting-edge digital innovations at the G20 Health Working Group meeting in Goa, India. Discussions centered on creating a digital health ecosystem, innovations in healthcare, technology aiding continuing care, and digital public health goods. Takeda’s digital health solutions, including MyPKFit, Synapse, and Athena, were presented at the event.

MyPKFit is an FDA-approved application that offers personalized and interactive prophylaxis treatment options. Synapse is a platform designed to enhance awareness and knowledge-sharing among healthcare professionals, engaging over 4000 healthcare professionals through scientific exchange and educational initiatives. The Athena App MVP is a digital health solution that empowers patients to easily track, understand, and communicate simple, robust measures of Quality of Life (QOL).

At Takeda Biopharmaceuticals, they are committed to leveraging digital solutions to transform healthcare and improve patient outcomes. Through their digital innovations, Takeda Biopharmaceuticals aims to drive healthcare access, enhance standards of care, and optimize patient benefits. Their participation in the G20 Health Working Group meeting provided a platform to showcase their digital capabilities and explore potential collaborations with G20 member countries and relevant international organizations.


Leave a Reply

Your email address will not be published. Required fields are marked *